Deferred Revenue
ResMed Deferred Revenue increased by 1.8% to $179.28M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.7%, from $160.45M to $179.28M. Over 4 years (FY 2021 to FY 2025), Deferred Revenue shows an upward trend with a 10.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase suggests strong sales of subscription-based services or bundled offerings, providing a predictable pipeline for future revenue recognition.
Detailed definition
Represents cash payments received from customers in advance of the company fulfilling its performance obligations, speci...
Peer comparison
High-growth software and services companies typically maintain larger deferred revenue balances relative to pure hardware manufacturers.
deferred_revenue_currentHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $109.61M | $112.53M | $111.65M | $112.45M | $108.67M | $108.20M | $133.91M | $141.04M | $138.07M | $146.72M | $148.90M | $150.75M | $152.55M | $157.19M | $156.51M | $160.45M | $166.03M | $167.78M | $176.05M | $179.28M |
| QoQ Change | — | +2.7% | -0.8% | +0.7% | -3.4% | -0.4% | +23.8% | +5.3% | -2.1% | +6.3% | +1.5% | +1.2% | +1.2% | +3.0% | -0.4% | +2.5% | +3.5% | +1.1% | +4.9% | +1.8% |
| YoY Change | — | — | — | — | -0.9% | -3.9% | +19.9% | +25.4% | +27.1% | +35.6% | +11.2% | +6.9% | +10.5% | +7.1% | +5.1% | +6.4% | +8.8% | +6.7% | +12.5% | +11.7% |
Deferred Revenue at Other Companies
Frequently Asked Questions
- What is ResMed's deferred revenue?
- ResMed (RMD) reported deferred revenue of $179.28M in Q1 2026.
- How has ResMed's deferred revenue changed year-over-year?
- ResMed's deferred revenue increased by 11.7% year-over-year, from $160.45M to $179.28M.
- What is the long-term trend for ResMed's deferred revenue?
- Over 4 years (2021 to 2025), ResMed's deferred revenue has grown at a 10.9% compound annual growth rate (CAGR), from $109.61M to $166.03M.
- What does deferred revenue mean?
- Money collected from customers for products or services that haven't been delivered yet but will be within a year.